Chemical Company Capital Markets Counsel in 2026: Frankfurt Matters

A general counsel who asks an assistant to find capital markets lawyers for chemical companies will usually get a list of New York offices. The deal record points to a wider map. Sartori & Partners data show that Frankfurt lawyers worked on 12.1% of chemicals deals in the 12 months to October 2026, and London lawyers on 18.3%. Munich and Brussels also appear on the sector's city list, so four of its seven cities are European. The practice mix is unusual as well: capital markets lawyers sat on 37.6% of the sector's deals, more than any other practice. For a chemical company planning a capital raise, the right counsel may sit in a German or English office as often as in Manhattan.

New York still comes first: lawyers there worked on 34.6% of chemicals deals. London comes second at 18.3%, ahead of Washington at 16.7%. Frankfurt follows at 12.1%, Munich at 7.5% and Brussels at 6.5%. Houston, the only other American city on the list, sits at 6.9%, below Frankfurt by 5.2 points. Each figure is the share of the sector's deals with a known lawyer location that had lawyers from that city on them. A deal staffed from London and Frankfurt counts in both, so the shares overlap and never add up to a total. The base is small, 356 chemicals deals in 12 months, so the shape matters more than the decimals. A chemicals mandate that runs only from a New York desk leaves out the cities where a large part of the sector's work is done; ask any firm on your list which German and London partners would join the team.

Technology and software is a useful yardstick, a large sector whose deal work runs through American offices. Of the ten cities on its list, London is the only one in Europe; the other nine are American cities. Compare the three cities that appear on both lists. London lawyers worked on 18.3% of chemicals deals against 15.0% of technology deals, a gap of 3.3 points. New York runs the other way, at 34.6% in chemicals against 38.7% in technology, and Washington stands at 16.7% against 19.6%. The technology list is built from 3,279 deals, so its shares are steadier than the chemicals ones. Even so, the direction is clear: chemicals work draws more on London and less on the two big American centers. A chemical company should not copy the counsel panel of a technology peer; its own map has a European half.

Capital markets lawyers worked on 37.6% of chemicals deals and corporate and M&A lawyers on 33.7%, a lead of 3.9 points. Banking and finance lawyers were on 10.1%. Across all dated deals the capital markets practice appears on 26.4%, so the chemicals rate is well above the practice's rate in the whole record. Technology shows the opposite order: corporate and M&A lawyers sat on 47.8% of its deals and capital markets lawyers on 24.0%. One deal can carry lawyers from several practices, so these shares measure presence and do not split the work between practices. For a chemical company, this means capital markets depth is a core test of any outside firm, even when the next mandate looks like a corporate deal.

Chemicals deals rose 33.7% year on year, at 373 in the latest settled 12 months against 279 a year earlier. The capital markets practice, counted across every client sector, rose 10.0%, from 11,838 to 13,024, and all dated deals rose 10.6%. No trend exists for capital markets work in chemicals alone, so these are separate readings set side by side. Client spread differs too. The sector's 356 deals came from 190 distinct clients, about 1.9 deals per client. The capital markets practice logged 12,684 deals for 4,924 clients, about 2.6 per client. In the Sartori & Partners deal record a count is matters on record, not fees. A chemical issuer comes back to the market less often than the practice's typical client, so a firm may know the sector without knowing your company: ask for the chemicals deals the proposed team ran in the past 12 months.

In the Sartori & Partners lateral database, moves of capital markets lawyers between firms held flat (+6.7%), at 609 against 571. Partner moves in the practice held flat (+1.1%), at 185 against 183. These are moves of lawyers, not deals, and they are set beside the sector's deal growth as context, not as its cause. Over three years, 1.7% of capital markets lateral moves ended in Frankfurt and 12.0% in London. Frankfurt lawyers are on a sizable share of chemicals deals while few capital markets lawyers change firms into that city. A chemical company should judge a firm's German capital markets team as it stands now, by the deals its partners have run, and not count on a hire to fill a gap mid-mandate.

No firm list ranks capital markets work in chemicals alone. The chemicals list below covers all of the sector's deal work, in every practice; the capital markets list covers all of the practice's deals, in every client sector. Four names appear on both: Davis Polk & Wardwell, Latham & Watkins, A&O Shearman and Clifford Chance. The first firm on the chemicals list sits in the 21-40 band of deals advised; firms show as a rank and a band, never an exact count. For a chemical company building a panel, the overlap is a reasonable short list to start from; then ask each firm on either list where its chemicals team works and which European offices it would staff.

Build the panel on the sector's own map. Frankfurt lawyers worked on 12.1% of chemicals deals and London lawyers on 18.3%, so a firm without strength in Germany and England covers only part of where the work is done. Put capital markets depth first, since that practice was on 37.6% of the sector's deals. Expect competition for partner time: the sector's deal count rose 33.7% year on year. Test sector experience deal by deal, because chemicals clients return to the market less often than the practice's average client. Sartori & Partners builds these figures from public law-firm announcements, firm websites and professional profiles, checked monthly.